1. Cognitive function and uremic toxins after kidney transplantation: An exploratory study
- Author
-
Roy P. C. Kessels, Bjӧrn K.I. Meijers, Jack F.M. Wetzels, Henriette de Loor, Elsemieke te Linde, and Claudette J.M. van Roij
- Subjects
cognition ,medicine.medical_specialty ,Alzheimer`s disease Donders Center for Medical Neuroscience [Radboudumc 1] ,medicine.medical_treatment ,030232 urology & nephrology ,kidney transplantation ,Original Investigations ,030204 cardiovascular system & hematology ,Gastroenterology ,03 medical and health sciences ,chemistry.chemical_compound ,Cognition ,All institutes and research themes of the Radboud University Medical Center ,0302 clinical medicine ,Renal Dialysis ,Internal medicine ,medicine ,Humans ,Neuropsychological assessment ,Uremic Toxins ,Dialysis ,Kidney transplantation ,Uremia ,Neuro- en revalidatiepsychologie ,medicine.diagnostic_test ,business.industry ,Neuropsychology and rehabilitation psychology ,Neuropsychology ,General Medicine ,medicine.disease ,Kidney Transplantation ,Transplantation ,biological toxins ,Phenylacetylglutamine ,chemistry ,Hemodialysis ,Renal disorders Radboud Institute for Health Sciences [Radboudumc 11] ,business ,Kidney disease ,transplantation - Abstract
BACKGROUND: Cognitive functions are altered in patients with CKD. However, it is suggested that cognitive functions improve after kidney transplantation, at least partially. A possible cause for this improvement could be the reduction of uremic retention solutes after transplantation. This study assessed the association between the changes in uremic toxin concentration with the changes in cognitive function in patients after kidney transplantation. METHODS: Ten recipients of kidney transplants were compared with 18 controls (nine patients on hemodialysis, and nine patients with CKD stage 4 or 5 [eGFR
- Published
- 2020